Structure
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
601 Gateway Blvd Ste 900, South San Fran...Phone Number
(650) 457-1978Website
www.structuretx.comRevenue
-Stock Symbol
GPCRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
1
About Structure
Structure Therapeutics is a science-driven, clinicalstage biopharmaceutical company committed to discovering and developing innovative oral smallmolecule therapies for chronic metabolic and cardiopulmonary diseases that currently lack effective treatments. Leveraging a nextgeneration structure-based drug discovery platform, the company focuses on targeting Gproteincoupled receptors (GPCRs) to build a robust pipeline of proprietary smallmolecule compounds. By prioritizing oral therapies over traditional biologic or peptide approaches, Structure Therapeutics aims to deliver scalable, accessible treatments that can reach more patients worldwide and address significant unmet medical needs.Explore more
Structure Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Structure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Structure recently announced quarterly report
Check if Structure has recently received funding, and reach out quickly before it becomes old news!
Check out if Structure is spiking on competitors!
Funding: Get notified immidiatlly once Structure has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Structure launches new products
Structure, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Structure
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Structure had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Structure as Masked Content
Find 3 more new buyers
Compare Similar Companies to Structure
Compare insights from companies similar to Structure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Structure is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Structure is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Structure.
Structure financials insights
Gather financial insights about Structure, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$26M
2022
Series B
$133M
2023
Stock Offering
$161M
Structure Tech Stack
A closer look at the technologies used by Structure
Most Recent Scoops
Hiring Plans
Structure has more open roles in Human Resources than it has had at any time in the past 12 months. Technologies mentioned include: Smartsheet.
Hiring Plans
Person-Based
Pharmaceuticals
Open Position
Open Position
Open Position
Structure News & Media
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity
Publication presented concurrently with oral presentation at American Diabetes Association’s 86th Scientific Sessions from ACCESS development program with aleniglipron, a once-daily oral small molecule GLP-1 receptor agonistStructure Therapeutics Announces Participation in Upcoming Investor Conferences
SAN FRANCISCO, May 26, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in two upcoming healthcare conferences in June:This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million
Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.Monashee Scales Back Its Bet on Structure Therapeutics
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Structure
Sign Up For FreeTo access detailed company insights
Structure Therapeutics is a science-driven, clinicalstage biopharmaceutical company committed to discovering and developing innovative oral smallmolecule therapies for chronic metabolic and cardiopulmonary diseases that currently lack effective treatments. Leveraging a nextgeneration structure-based drug discovery platform, the company focuses on t... Read More
